Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make a comparative assessment of the adequacy of funding for research and innovation for (a) less survivable cancers and (b) other cancer types.

Research is crucial in tackling cancer, which is why the Department invests £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR). Cancer is one of the largest areas of spend at over £141.6 million in 2024/25, reflecting its high priority.

These investments are pivotal to informing efforts to improve cancer prevention, treatment, and outcomes. An example of this investment is the Imperial College London research on breath tests to detect less survivable cancers, with further information available at the following link:

https://imperialbrc.nihr.ac.uk/2023/06/05/imperial-led-uk-cancer-breath-tests-reach-final-stages/

Another example of Government investment was the launch of the NIHR’s national Brain Tumour Research Consortium in September 2024, which is bringing together researchers from a range of different disciplines and institutions with the aim of making scientific advances in how we prevent, detect, manage, and treat rare and less-survivable brain tumours in adults and children.

The NIHR continues to welcome funding applications for research into less common cancers and other cancer types. The forthcoming National Cancer Plan will include further details on how the National Health Service will improve diagnosis and outcomes for all cancer patients in England, including for less common cancers, and other cancer types.